[Primary prevention of esophageal varices].
Sieveking
C F
CF
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000517:prevention & control* / Q000628:therapy; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000628:therapy; D015911:Sclerotherapy
D000319:Adrenergic beta-Antagonists